Respiratory Motion, Inc. (RMI)

Respiratory Motion Inc. has developed and commercialized the first and only FDA cleared respiratory monitor, the ExSpiron®, that is able to alert caregivers about deteriorating respiration in advance of adverse events, in advance of other methods and in time to make a difference. Acting as an “EKG for the Lungs” the ExSpiron increases patient safety while decreasing hospital costs and is becoming the standard of care for respiratory monitoring.